Concepedia

Jennifer Busby

JB

Statistics

Publications

6

Citations

914

H-Index

6

Active since

2006

Affiliations

Constellation Pharmaceuticals (United States)(Current)

Jennifer Busby is an author at Constellation Pharmaceuticals (United States) specializing in life sciences, molecular oncology, and oncology.

Publications per year

2006–2016

6

Publications

6

An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells

Maia Vinogradova, Victor Gehling, Amy Gustafson et al. · Nature Chemical Biology · 2016 · 357 citations · Full text

, , +14

An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition

Brian Egan, Chih-Chi Yuan, Madeleine Craske et al. · PLoS ONE · 2016 · 167 citations · Full text

, , +17

Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth

Shivani Garapaty-Rao, Christopher G. Nasveschuk, Alexandre Gagnon et al. · Chemistry & Biology · 2013 · 154 citations

, , +8

EZH2 Inhibitor Efficacy in Non-Hodgkin’s Lymphoma Does Not Require Suppression of H3K27 Monomethylation

William D. Bradley, Shilpi Arora, Jennifer Busby et al. · Chemistry & Biology · 2014 · 148 citations

, , +11

Trizol-based method for sample preparation and isoelectric focusing of halophilic proteins

P. Aaron Kirkland, Jennifer Busby, Stanley M. Stevens et al. · Analytical Biochemistry · 2006 · 65 citations

, , +13

1–5 of 6